首页> 外国专利> PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, KIT AND METHOD FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS

PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, KIT AND METHOD FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS

机译:用于治疗和/或预防子宫肌瘤和/或子宫内膜异位的药物联合会,白藜芦醇和孕激素的使用,用于治疗和/或预防子宫肌瘤和/或内在肿瘤的药物组合物,用于治疗和/或预防和控制子宫肌瘤的药物用于治疗和/或预防子宫肌瘤和/或子宫内膜异位症

摘要

The present invention relates to a combination of resveratrol with progestogen, and medicaments and pharmaceutical compositions containing the same, which are useful in the treatment and/or prevention of myoma and/or endometriosis, providing their size reduction and the control of related symptoms. Said association may additionally comprise an estrogen component. A treatment method and a kit are also objects of this invention.
机译:本发明涉及白藜芦醇与孕激素的组合,以及包含其的药物和药物组合物,其可用于治疗和/或预防肌瘤和/或子宫内膜异位,提供其尺寸减小和相关症状的控制。所述结合可以另外包含雌激素成分。治疗方法和试剂盒也是本发明的目的。

著录项

  • 公开/公告号EP2617425A1

    专利类型

  • 公开/公告日2013-07-24

    原文格式PDF

  • 申请/专利权人 LIBBS FARMACÊUTICA LTDA.;

    申请/专利号EP20110824381

  • 发明设计人 DA SILVA MAIA FILHO HUGO;

    申请日2011-09-15

  • 分类号A61K31/565;A61K31/585;A61K31/57;A61P15;

  • 国家 EP

  • 入库时间 2022-08-21 16:29:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号